Institut für Mikrobiologie der Bundeswehr

What Institut für Mikrobiologie der Bundeswehr does

The Institut für Mikrobiologie der Bundeswehr (Bundeswehr Institute of Microbiology) is a German federal government research institution dedicated to medical biological defense (medizinischer B-Schutz). It is a departmental research facility (Ressortforschungseinrichtung) of the German Federal Ministry of Defense, headquartered in Munich with 39 employees. The institute conducts scientific research on a broad spectrum of infectious pathogens and biotoxins that could potentially be misused as biological warfare agents, and serves primarily the German Armed Forces (Bundeswehr), with secondary service to public health authorities and the international scientific community.

The institute's work is organized around three core research competence areas: KB Bakterien und Toxine (Bacteria and Toxins), KB Viren und intrazelluläre Erreger (Viruses and Intracellular Pathogens), and KB Medizinische Biologische Aufklärung und Bioforensik (Medical B-Reconnaissance and Bioforensics). The bioforensics competence area subdivides into mobile B-reconnaissance and verification, technical development and diagnostic platforms, microbial genomics and bioinformatics, and a central diagnostic unit. Supporting capabilities include a deployable mobile laboratory, imaging technologies, diagnostic services, consultation laboratories (Konsiliarlabore), and an EU Reference Laboratory designation. The institute has been the Munich partner site of the German Center for Infection Research (DZIF) since 2010 and was designated part of the EU Reference Laboratories for Public Health in 2025.

The institute does not operate a commercial revenue model. It is funded through the German federal defense budget and does not sell products or services through commercial channels. Outreach and knowledge dissemination occur through peer-reviewed scientific publications, detailed annual reports produced since 2003, the biennial Medical Biodefense Conference (MBDC) organized since 1994, and the institute's bilingual website. The MBDC has grown into an international civil-military event that regularly draws over 500 participants from more than 50 nations and is registered as a German confidence-building measure at NATO and UNODA.

Name

Institut für Mikrobiologie der Bundeswehr

Legal name

Institut für Mikrobiologie der Bundeswehr

Website

https://instmikrobiobw.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Institut für Mikrobiologie der Bundeswehr is a German federal defense research institute in Munich that studies biological warfare agents and dangerous pathogens to protect Bundeswehr military personnel and support public health authorities and the international scientific community.

Ownership category

akta.pro rank

Product category

Defense Microbiology Research Services

NAICS

Medical and Diagnostic Laboratories (62151), National Security (928110)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biothreat/Biocontainment & Select Agent Public Health Laboratories (HLAJAIAL)

akta.pro secondary industries

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Military Operations & Force Readiness (BPAIAHAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Medical biodefense research
• Pathogen detection diagnostics
• Biological threat forensics
• Microbiology reference laboratory
• Military infectious disease research

Headquarters

HQ city

München

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Marketing channels4 records

Core offering

The Institut für Mikrobiologie der Bundeswehr (Bundeswehr Institute of Microbiology) is a German Armed Forces departmental research institution that delivers applied research, specialized diagnostics, and consulting in medical biological defense. It operates high-containment laboratories (including BSL-3/BSL-4), maintains EU Reference Laboratory and Konsiliarlabor designations, deploys mobile laboratory capabilities, and runs international biosecurity programmes such as EUROBIODART and the German Biosecurity Programme.

Product overview

The Institut für Mikrobiologie der Bundeswehr is a research institution of the German Armed Forces dedicated to medical biological defense (B-Schutz). The portfolio consists of three core research competence areas: KB Bakterien und Toxine (Bacteria & Toxins), KB Viren und intrazelluläre Erreger (Viruses & Intracellular Pathogens), and KB Med. B-Aufklärung & Bioforensik (Medical B-Reconnaissance & Bioforensics, comprising mobile reconnaissance, technical development & diagnostic platforms, microbial genomics & bioinformatics, and central diagnostics). Additional capabilities include mobile laboratories, imaging technologies, diagnostic services, EU reference laboratory functions, and consultation laboratories. The institute also operates the International Biosecurity program and organizes the biennial Medical Biodefense Conference (MBDC).

Differentiator

Problem solved

Functional benefit

Products and services

• Competence Area Bacteria and Toxins Applied research and specialized diagnostics on bacteria, bacterial toxins, and toxin-producing organisms relevant to medical biological defense, serving Bundeswehr medical services and partner authorities.
• Competence Area Viruses and Intracellular Pathogens Applied research and diagnostics on viruses and intracellular pathogens (including work conducted in BSL-3 and BSL-4 laboratories) to support Bundeswehr force health protection.
• Competence Area Medical Biological Reconnaissance and Bioforensics Field-deployable biological reconnaissance and forensic analysis services for biological threat attribution, including operations of the institute's mobile laboratory and bioforensic casework.
• EU Reference Laboratory Functions Designated EU Reference Laboratory services for high-consequence pathogens, providing reference diagnostics and confirmatory testing to public health authorities and EU partner institutions.
• Konsiliarlabore (Consultation Laboratories) Specialized consultation and confirmatory diagnostic laboratory services for specific pathogen groups, supporting German public health and clinical partners with expert microbiological analyses.
• International Biosecurity Programme (German Biosecurity Programme / EUROBIODART) Bilateral and multilateral capacity-building programmes in biological risk management, biosafety, biosecurity, and biological weapons non-proliferation delivered to partner states and international institutions.
• Medical Biodefense Conference (MBDC) Recurring scientific conference hosted by the institute to convene international researchers and practitioners on medical biodefense topics, held in Munich.
• Institute Annual Report Publicly available annual report documenting the institute's research, personnel, and operational activities, distributed in print and digital form.

Quantifiable outcome

• 335 Bacillus anthracis samples analyzed for antibiotic susceptibility testing guidelines developed with EUCAST
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• EU Reference Laboratories for Public HealthcoreStrategic or Co-development Partner · 1 January 2025Since 2025, the institute is part of the EU Reference Laboratories for Public Health, providing specialized diagnostic capabilities at the European level.
• Deutsches Zentrum für Infektionsforschung (DZIF)coreStrategic or Co-development Partner · 1 January 2010Since 2010, the institute forms the Partnerstandort München (Munich partner site) of the German Center for Infection Research together with Technische Universität München, Ludwig-Maximilian-Universität, and Helmholtz-Zentrum. This partnership advances collaborative infection research.
• UNODA (United Nations Office for Disarmament Affairs)majorStrategic or Co-development PartnerCooperation with UNODA to strengthen the Biological Weapons Convention (BWÜ). Listed as German confidence-building measure at NATO and UNODA.
• Joint Action SHARPmajorStrategic or Co-development PartnerCollaborated within Joint Action SHARP (Strengthened International Health Regulations and Preparedness in the EU) to advance treatment of anthrax.
• EUCAST (European Committee on Antimicrobial Susceptibility Testing)majorStrategic or Co-development PartnerCollaborated with EUCAST to establish specific breakpoint values for evaluating susceptibility/resistance of Bacillus anthracis to antibiotics suitable for therapy.
• EUROBIODARTmajorStrategic or Co-development PartnerPart of EUROBIODART program under the German Biosecurity Programme, aiming to strengthen readiness, expertise and transnational cooperation in diagnostics, detection, investigation and assessment of use of biological agents.
• Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata (Italy)minorStrategic or Co-development PartnerResearch partner in anthrax antibiotic study within Joint Action SHARP.
• Robert Koch-Institut (Germany)majorStrategic or Co-development PartnerCollaborating partner in anthrax antibiotic research study.
• Friedrich-Loeffler-Institut (Germany)minorStrategic or Co-development PartnerResearch partner in anthrax antibiotic susceptibility study.
• Sciensano (Belgium)minorStrategic or Co-development PartnerInternational research partner in anthrax antibiotic study.
• National Veterinary Research Institute Pulawy (Poland)minorStrategic or Co-development PartnerInternational partner in anthrax antibiotic susceptibility research.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Friedrich-Loeffler-Institut (FLI): Germany's federal research institute for animal health and veterinary public health, co-partner in the anthrax antibiotic susceptibility work with the institute. Comparable in being a German federal Ressortforschungseinrichtung with select-agent and reference-laboratory functions, focused on the veterinary and zoonotic side.
• Institut de Recherche Biomédicale des Armées (IRBA): France's military biomedical research institute, combining medical countermeasures, infectious disease research, and biological defense within the French armed forces. Closest European national counterpart in scope, mission, and organizational placement within a defense ministry.
• Spiez Laboratory: Swiss federal NBC defense laboratory operating as a designated international reference and confidence-building facility under the Biological Weapons Convention. Functionally equivalent to the institute's role as a NATO/UNODA-listed confidence-building measure for Germany.
• FOI (Swedish Defence Research Agency): Sweden's defense research agency with a dedicated CBRN (chemical, biological, radiological, nuclear) defense division covering biological threat characterization, diagnostics, and bioforensics. Operates a similar select-agent and reference-laboratory footprint within a Nordic defense ministry structure.
• USAMRIID (US Army Medical Research Institute of Infectious Diseases): The US military's lead biomedical research laboratory for medical biological defense against select agents and biothreats. Operates the closest analog mandate to Institut für Mikrobiologie der Bundeswehr — diagnostic platforms, mobile labs, microbial genomics, and reference-laboratory functions — within another country's armed forces.
• Defence Science and Technology Laboratory (Dstl): UK Ministry of Defence laboratory covering chemical, biological, and radiological defense including biological threat characterization and diagnostics. Provides the British counterpart portfolio of bioforensics, reference diagnostics, and deployable capability tied to NATO preparedness.
• Bundeswehr Institute for Pharmacology and Toxicology: Sister Ressortforschungseinrichtung of the Bundeswehr in Munich covering chemical defense, toxicology, and pharmacology. Shares organizational structure, funding model, and joint mandate to protect soldiers from non-conventional threats, providing a direct in-system peer for benchmarking.

Regional players

• National Microbiology Laboratory (Public Health Agency of Canada): Canada's national reference microbiology laboratory operating high-containment and bioforensics capabilities aligned with select-agent work and outbreak response. Comparable in scope (CL-4 diagnostics, genomics, mobile capability) but serves a different national jurisdiction.

Broad incumbents

• Robert Koch-Institut (RKI): Germany's federal public health institute and primary national reference laboratory for infectious diseases. Overlaps with the institute on outbreak diagnostics, surveillance, and select-agent work but covers a broader civilian public health mandate rather than military biological defense.
• UK Health Security Agency (UKHSA) Rare and Imported Pathogens Laboratory: UK's primary public-health reference laboratory for high-consequence pathogens and clinical diagnostics, housed within a larger agency with broad health-security responsibilities. Comparable diagnostic and reference functions for select agents but with a civilian rather than military mandate.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/institut-f%C3%BCr-mikrobiologie-der-bundeswehr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut für Mikrobiologie der Bundeswehr